Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05706532 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cardiovascular and Cerebrovascular Control in Healthy Subjects

Study acronym: CardioSan
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv6
  2. Enrollment target: 30 to 60 Primary and study completion dates: Jun 2024 to Oct 2027v5 Show 1 more changeShow less
    • Primary and study completion dates: Jun 2024 to Oct 2027
  3. Primary and study completion dates: Dec 2023 to Jun 2024v4
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Feb 2023 to May 29, 2023 · Study site revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Feb 2023 to May 29, 2023
    • Study site revised

    See this version in full on ClinicalTrials.gov ↗

  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to evaluate autonomic function and cerebrovascular control in 60 healthy subjects by means of noninvasive analysis of time series variability. To this extent, heart period, systolic and mean arterial blood pressure, cerebral blood velocity, peripheral resistances, respiration will be recorded from subjects during an orthostatic challenge. The interactions between autonomic cardiovascular function, cerebrovascular and peripheral control will be evaluated exploiting the most advanced signal processing techniques.
Trial Details
NCT Number NCT05706532
Lead Sponsor IRCCS Policlinico S. Donato
Conditions Healthy, Autonomic Nervous System, Cerebral Autoregulation
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov